Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT.

Blood ·Vol. 87 ·No. 9 ·1996-05-01 ·Pages 4011-3

Slavin S, Naparstek E, Nagler A, Kapelushnik Y, Ackerstein A, Or R

Abstract

暂无摘要

MeSH Terms

Bone Marrow Transplantation Humans Immunotherapy, Adoptive Leukemia/therapy Lymphocyte Transfusion Recurrence

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

Slavin S

Naparstek E

Nagler A

Kapelushnik Y

Ackerstein A

Or R

Article Info

Journal

Blood

Abbr.

Blood

ISSN

0006-4971

Published

1996-05-01

Pages

4011-3

Language

English

Region

United States

NLM ID

7603509

Subset

Corrections

CommentOn

PMID: 7655033

External Links

Analysis Services